|
1. Yester J, Kühn B. Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration. Curr Cardiol Rep 2017; 19(2): 13-. 2. Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, et al. Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci 2019; 76(9): 1681-95. 3. Guo X, Bai Y, Zhang L, Zhang B, Zagidullin N, Carvalho K, et al. Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications. Stem Cell Res The 2018; 9(1): 1-12. 4. Kazemzadeh N, Sarvari MH, Jani MR, Razmara MR. Stem Cells Therapy For Peripheral Arterial Disorders. iranian journal of cardiovascular nursing. 2015; 3(4): 64- 73. [in Persian] 5. Bozorgmehr M, Gurung S, Darzi S, Nikoo S, Kazemnejad S, Zarnani AH, et al. Endometrial and menstrual blood mesenchymal stem/stromal cells: biological properties and clinical application. Front Cell Dev Biol 2020; 8. 6. Darzi S, Werkmeister JA, Deane JA, Gargett CE. Identification and characterization of human endometrial mesenchymal stem/stromal cells and their potential for cellular therapy. Stem Cells Transl Med 2016; 5(9): 1127-32. 7. Guo Y, Yu Y, Hu S, Chen Y, Shen Z. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis 2020; 11(5): 1-10. 8. Rahimi M, Zarnani AH, Mohseni-Kouchesfehani H, Kazemnejad S. Evaluation of differentiation potential of menstrual blood-derived stem cells to cardiomyocytes in vitro. Daneshvar Med 2016; 23(123): 31-42. [in Persian] 9. Szaraz P, Gratch YS, Iqbal F, Librach CL. In vitro differentiation of human mesenchymal stem cells into functional cardiomyocyte-like cells. J Vis Exp 2017; (126): e55757. 10. Paige SL, Plonowska K, Xu A, Wu SM. Molecular regulation of cardiomyocyte differentiation. Circ Res 2015; 116(2): 341-53. 11. Sun X, Li H, Zhu Y, Xu P, Zuo Q, Li B, et al. 5-Azacytidine-Induced Cardiomyocyte Differentiation of Very Small Embryonic-Like Stem Cells. Stem Cells Int 2020; 2020: 5162350. 12. Wang J, Greene SB, Bonilla-Claudio M, Tao Y, Zhang J, Bai Y, et al. Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism. Dev Cell 2010; 19(6): 903-12. 13. Alfar EA, El-Armouche A, Guan K. MicroRNAs in cardiomyocyte differentiation and maturation. Oxford University Press; 2018. 14. Katz MG, Fargnoli AS, Kendle AP, Hajjar RJ, Bridges CR. The role of microRNAs in cardiac development and regenerative capacity. Am J Physiol Heart Circ Physiol 2016; 310(5): H528-H41. 15. Wang Q, Xu C, Zhao Y, Xu Z, Zhang Y, Jiang J, et al. miR-26b-3p regulates human umbilical cord-derived mesenchymal stem cell proliferation by targeting estrogen receptor. Stem Cells Dev 2016; 25(5): 415-26. 16. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, et al. MicroRNA‐26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226(4): 1035-43. 17. Sun J, Yan P, Chen Y, Chen Y, Yang J, Xu G, et al. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway. Diagn Pathol 2015; 10(1): 1-9. 18. Dill H, Linder B, Fehr A, Fischer U. Intronic miR-26b controls neuronal differentiation by repressing its host transcript, ctdsp2. Genes Dev 2012; 26(1): 25-30. 19. Icli B, Wara A, Moslehi J, Sun X, Plovie E, Cahill M, et al. MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res 2013; 113(11): 1231-41. 20. Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, et al. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 2013; 123(5): 1939-51. 21. Wang D, Liu C, Wang Y, Wang W, Wang K, Wu X, et al. Impact of miR‐26b on cardiomyocyte differentiation in P19 cells through regulating canonical/non‐canonical Wnt signalling. Cell Prolif 2017; 50(6): e12371. 22. Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, et al. Mesenchymal stern cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 2004; 229(7): 623-31. 23. Tirosh-Finkel L, Zeisel A, Brodt-Ivenshitz M, Shamai A, Yao Z, Seger R, et al. BMP-mediated inhibition of FGF signaling promotes cardiomyocyte differentiation of anterior heart field progenitors. Development 2010; 137(18): 2989-3000. 24. Rowton M, Guzzetta A, Rydeen AB, Moskowitz IP. Control of cardiomyocyte differentiation timing by intercellular signaling pathways. Semin Cell Dev Biol 2021; 118: 94-106. 25. Guo Y, Pu WT. Cardiomyocyte maturation: new phase in development. Circulation research. 2020; 126(8): 1086-106. 26. Buikema JW, Zwetsloot P-PM, Doevendans PA, Domian IJ, Sluijter JP. Wnt/β-catenin signaling during cardiac development and repair. J Cardiovasc Dev Dis 2014; 1(1): 98-110. 27. Mu F, Huang J, Xing T, Jing Y, Cui T, Guo Y, et al. The Wnt/β-catenin/Lef1 pathway promotes cell proliferation at least in part through direct upregulation of miR-17-92 cluster. Front Genet 2019; 10: 525. 28. Marvin MJ, Di Rocco G, Gardiner A, Bush SM, Lassar AB. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev 2001; 15(3): 316-27. 29. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001; 28(3): 276-80. 30. Snyder M, Huang XY, Zhang JJ. Stat3 directly controls the expression of Tbx5, Nkx2. 5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells. J Biol Chem 2010; 285(31): 23639-46.
|
.png)
.png){kind=logo}
